Dr Gordon Moran

Dr Gordon Moran

Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH

+44 115 82 31090 View full bio
Associate Professor of Gastroenterology

Dr Moran did his undergraduate medical training at University of Malta Medical School and was awarded an MD in 1999. He completed his basic postgraduate training at St. Luke’s Hospital in Malta and gained membership of the Royal College of Physicians of the United Kingdom in 2002. He was appointed to the higher specialist training programme in Gastroenterology in the West Midlands, UK in 2004. After completion of his PhD studies at the University of Manchester in 2011 he advanced his clinical training in Inflammatory Bowel disease by undertaking a one year advanced clinical fellowship in Inflammatory Bowel disease at the University of Calgary, Canada under the supervision of Professors Remo Panaccione and Professor Subrata Ghosh.

He was appointed as a Clinical Associate Professor at the University of Nottingham in October 2013. He is academic training lead for the Nottingham Digestive Diseases. As from 2014, he is an Inflammatory Bowel Disease Expert reviewer for the National Institute of Health Research Trent Clinical Research Network and an Inflammatory Bowel Disease, Clinical Research Group Committee member for the British Society of Gastroenterology.

He is an editorial board member of the Journal of Crohn’s and Colitis and an Inflammatory Bowel disease expert reviewer for the British Journal of Nutrition, The Inflammatory Bowel Disease Journal, International Journal of Obesity, Clinical Nutrition, Expert Reviews in Gastroenterology and Hepatology and CORE.

Title Start Date Status
Eating behaviour in Crohn’s disease 1st June 2015 In Recruitment
A Randomised, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicafors 29th January 2016 In Recruitment
A new MR-based Perianal Crohn’s disease activity score: A multi-centre study (The MAP study) 24th November 2016 In Recruitment
A new MRI-based disease measure in Ulcerative Colitis – Optimisation studies in Healthy Volunteers 1st January 2018 In Recruitment
The PRognostic effect of Environmental factors in Crohn’s and Colitis 1st May 2019
Reduced Intestinal Motility in Inflammatory Crohn’s Disease (MIC 2) 1st May 2015 In Recruitment
A Phase 2b, randomised, double blind, placebo controlled, parallel-group, multicentre protocol to ev 1st January 2017 In Recruitment
A Phase 3, long-term active treatment extension study of mongersen (GED-0301) in subjects with Crohn 1st November 2016 Active
Autologous Stem cell Transplantation In refractory Crohn’s disease – Low Intensity Therapy Evaluatio 27th June 2018 Active
Reduced intestinal motility in inflammatory Crohn’s Disease optimisation studies on healthy voluntee 10th August 2015 Ended
Muscle physiology & function in Crohn’s disease and non-alcoholic liver disease 1st January 2016 In Recruitment
The GEM Project: A Multidisciplinary Study on the Genetic, Environmental and Microbial Interactions 1st February 2015 In Recruitment
Non-invasive approaches to identify the cause of fatigue in inflammatory bowel disease patients 30th July 2018 In Recruitment
Exercise therapy to treat abnormalities in appetite and food intake in active Crohn’s disease (Exerc 1st January 2015 Active
Altered appetite in Crohn’s disease: The role of the enteroendocrine axis (BROAD) 1st December 2014 In Recruitment
STopping Aminosalicylate Therapy in Inactive Crohn’s Disease (STATIC) Study: A Randomized, Open-labe 1st April 2019 In Recruitment
Clinical predictors of thiopurine-related adverse events in Crohn’s disease
Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with I
Acetarsol in the management of mesalazine-refractory ulcerative proctitis: a tertiary-level care exp
Practice pattern variability in the management of acute severe colitis: a UK provider survey
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bow
Novel concepts in inflammatory bowel disease
The Pattern of Underlying Cause of Death in Patients with Inflammatory Bowel Disease in England: A R
Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease
Ustekinumab: a novel therapeutic option in Crohn’s disease
MRI assessment of the postprandial gastrointestinal motility and peptide response in healthy humans
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroente
Evolution of treatment targets in Crohn’s disease
Ustekinumab for the treatment of Crohn’s disease: can it find its niche?
Literature review: impacts of socioeconomic status on the risk of inflammatory bowel disease and its
Surgical Rates for Crohn’s Disease are Decreasing: A Population-Based Time Trend Analysis and Valida
Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with I
Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related qualit
Tofacitinib in ulcerative colitis
Orbital Inflammatory Complications of Crohn’s Disease: A Rare Case Series
Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related qualit
Magnetic resonance imaging biomarkers of gastrointestinal motor function and fluid distribution